Company / CapEx per Share
Ernexa Therapeutics Inc. CapEx per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.11
FY2025
5-year range
$0.00 / $0.33
FY2021-FY2025
Trend
+2966.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share changed +2967% YoY in FY2025, a notable deviation from the 9-year average annual change of +1629%.
Based on SEC 10-K filings.
0.11 in FY2025 with a 10-year CAGR of +28.1%.
Improved from $0.06 to $0.11 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -20.2%
- 10-Year CAGR
- +28.1%
Key checks
Key Insights
- In FY2025, capex per share increased 2966.8% year-over-year.
- Peak capex per share was recorded in FY2016.
- Lowest capex per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.11 | +2966.8% |
| FY2024 | $0.00 | -93.9% |
| FY2023 | $0.06 | -82.6% |
| FY2020 | $0.33 | +47.7% |
| FY2019 | $0.23 | -21.9% |
| FY2018 | $0.29 | +6151.5% |
| FY2017 | $0.00 | -99.1% |
| FY2016 | $0.54 | +5829.0% |
| FY2015 | $0.01 | -35.9% |
| FY2014 | $0.01 | -18.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026